Aqr Capital Management LLC Vericel Corp Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 6,029 shares of VCEL stock, worth $350,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,029

Previous 10,701 43.66%

Holding current value

$350,164

Previous $490,000 48.16%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $197,392 - $250,232	-4,672 Reduced 43.66%	6,029 $254,000
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $223,857 - $283,914	-5,367 Reduced 33.4%	10,701 $490,000
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $335,151 - $539,312	10,306 Added 178.86%	16,068 $835,000
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $76,631 - $92,131	-2,484 Reduced 30.12%	5,762 $205,000
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $123,622 - $153,114	-3,901 Reduced 32.11%	8,246 $276,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $4,350 - $5,755	150 Added 1.25%	12,147 $456,000
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $28,071 - $36,887	-1,177 Reduced 8.93%	11,997 $351,000
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $706 - $1,094	40 Added 0.3%	13,174 $347,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $5,044 - $7,256	223 Added 1.73%	13,134 $305,000
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $434 - $749	-19 Reduced 0.15%	12,911 $325,000
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $215,494 - $322,017	-6,122 Reduced 32.13%	12,930 $508,000
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $14,229 - $18,343	307 Added 1.64%	19,052 $930,000
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $451,468 - $648,602	9,565 Added 104.19%	18,745 $984,000
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $23,073 - $44,372	-746 Reduced 7.52%	9,180 $510,000
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $203,996 - $346,783	-11,009 Reduced 52.59%	9,926 $307,000
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $393,174 - $512,090	-26,783 Reduced 56.13%	20,935 $388,000
Q2 2020 Aug 17, 2020	SELL	$8.5 - $15.82 $596,079 - $1.11 Million	-70,127 Reduced 59.51%	47,718 $659,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $506,296 - $1.34 Million	-69,834 Reduced 37.21%	117,845 $1.08 Million
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $484,759 - $675,916	-35,204 Reduced 15.79%	187,679 $3.27 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $2.7 Million - $3.58 Million	-180,702 Reduced 44.77%	222,883 $3.37 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $345,410 - $434,696	-23,012 Reduced 5.39%	403,585 $7.62 Million
Q1 2019 May 14, 2019	SELL	$16.23 - $20.29 $2.48 Million - $3.1 Million	-152,806 Reduced 26.37%	426,597 $7.47 Million
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $2.67 Million - $4.57 Million	247,860 Added 74.76%	579,403 $10.1 Million
Q3 2018 Nov 15, 2018	BUY	$9.1 - $14.8 $2.48 Million - $4.04 Million	272,995 Added 466.28%	331,543 $4.69 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $562,060 - $854,800	58,548 New	58,548 $568,000

Others Institutions Holding VCEL

# of Institutions

278

Shares Held

48.4M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.74B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Vericel Corp Transaction History